RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems for the diagnostic imaging industry, including picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of images in the field of mammography, as well as AI solutions for lung and prostate cancer. As of December 31, 2021, it owned and managed 347 centers in Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. The company was founded in 1981 and is headquartered in Los Angeles, California.
P/B ratio for RadNet, Inc. (RDNT)
P/B ratio as of 2023: 3.51
According to RadNet, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.51. At the end of 2022 the company had a P/B ratio of 3.18.
P/B ratio history for RadNet, Inc. from 1995 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 3.51 |
| 2022 | 3.18 |
| 2021 | 6.91 |
| 2020 | 6.01 |
| 2019 | 6.65 |
| 2018 | 3.85 |
| 2017 | 7.69 |
| 2016 | 6.15 |
| 2015 | 8.31 |
| 2014 | 65.41 |
| 2013 | -817.06 |
| 2012 | -36.25 |
| 2011 | -1.12 |
| 2010 | -1.26 |
| 2009 | -0.98 |
| 2008 | -1.48 |
| 2007 | -5.03 |
| 2006 | -1.37 |
| 2005 | -0.22 |
| 2004 | -0.35 |
| 2003 | -0.35 |
| 2002 | -0.64 |
| 2001 | -0.83 |
| 2000 | -0.29 |
| 1999 | -0.06 |
| 1998 | -0.06 |
| 1997 | -0.70 |
| 1996 | -0.58 |
| 1995 | -0.97 |